$Pfizer(PFE)$ $Moderna, Inc.(MRNA)$ The best case scenario for this Company is to get Pfizer to buy the entire company for roughly $11/share.
Pfizer though will probably merely want to do an EU agreement like the HLS agreement so the new CEO needs to make them pay
through the nose to get Europe so that it becomes worthwhile to simply buy the company outright.
Pfizer can easily make Vascepa a worldwide very profitable division but Amarin will never and this is why Karim should bluff hard and then extract an offer from $PFE, any offer.
Probably won't happen though because management is so great at making bonehead decisions.
精彩评论